FRESENIUS MEDICAL CARE FRANCE : revenue, balance sheet and financial ratios

FRESENIUS MEDICAL CARE FRANCE is a French company founded 126 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in FRESNES (94260), this company of category ETI shows in 2024 a revenue of 148.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - FRESENIUS MEDICAL CARE FRANCE (SIREN 652025289)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 148 464 060 € 147 589 028 € 149 615 639 € 146 677 547 € 138 938 335 € 129 006 291 € 122 778 965 € 116 441 959 € 112 029 007 €
Net income 8 170 381 € 3 667 727 € 5 783 944 € 3 096 578 € 1 770 083 € 254 755 € 4 379 720 € 4 472 833 € 5 335 355 €
EBITDA -1 985 887 € 973 178 € 9 176 823 € 7 655 739 € 6 360 836 € 6 992 541 € 11 061 067 € 12 586 331 € 11 760 855 €
Net margin 5.5% 2.5% 3.9% 2.1% 1.3% 0.2% 3.6% 3.8% 4.8%

Revenue and income statement

In 2024, FRESENIUS MEDICAL CARE FRANCE achieves revenue of 148.5 M€. Revenue is growing positively over 9 years (CAGR: +3.6%). Vs 2023: +1%. After deducting consumption (85.4 M€), gross margin stands at 63.0 M€, i.e. a rate of 42%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -2.0 M€, representing -1.3% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 8.2 M€, i.e. 5.5% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

148 464 060 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

63 030 656 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-1 985 887 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

15 827 002 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

8 170 381 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-1.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 94%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

93.84%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

30.685%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-6.366%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-3.662

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.1%

Solvency indicators evolution
FRESENIUS MEDICAL CARE FRANCE

Sector positioning

Debt ratio
93.84 2024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Average

In 2024, the debt ratio of FRESENIUS MEDICAL CARE FR... (93.84) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
30.68% 2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Average

In 2024, the financial autonomy of FRESENIUS MEDICAL CARE FR... (30.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-3.66 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.09 years
Excellent -50 pts over 3 years

In 2024, the repayment capacity of FRESENIUS MEDICAL CARE FR... (-3.66) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 217.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

217.152

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-89.831

Liquidity indicators evolution
FRESENIUS MEDICAL CARE FRANCE

Sector positioning

Liquidity ratio
217.15 2024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Good +9 pts over 3 years

In 2024, the liquidity ratio of FRESENIUS MEDICAL CARE FR... (217.15) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-89.83x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.41x
Q3: 6.25x
Average -29 pts over 3 years

In 2024, the interest coverage of FRESENIUS MEDICAL CARE FR... (-89.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 131 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 59 days. The gap of 72 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 54 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 159 days of revenue, i.e. 65.7 M€ to permanently finance. Over 2016-2024, WCR increased by +100%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

65 653 777 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

131 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

59 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

54 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

159 j

WCR and payment terms evolution
FRESENIUS MEDICAL CARE FRANCE

Positioning of FRESENIUS MEDICAL CARE FRANCE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of FRESENIUS MEDICAL CARE FRANCE is estimated at 21 656 264 € (range 11 309 623€ - 67 269 452€). The price/revenue ratio is 0.21x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
124 transactions
11309k€ 21656k€ 67269k€
21 656 264 € Range: 11 309 623€ - 67 269 452€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

Revenue Multiple 30%
148 464 060 € × 0.21x
Estimation 31 619 044 €
17 146 258€ - 95 774 605€
Net Income Multiple 20%
8 170 381 € × 0.8x
Estimation 6 712 096 €
2 554 672€ - 24 511 723€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare FRESENIUS MEDICAL CARE FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about FRESENIUS MEDICAL CARE FRANCE

What is the revenue of FRESENIUS MEDICAL CARE FRANCE ?

The revenue of FRESENIUS MEDICAL CARE FRANCE in 2024 is 148.5 M€.

Is FRESENIUS MEDICAL CARE FRANCE profitable?

Yes, FRESENIUS MEDICAL CARE FRANCE generated a net profit of 8.2 M€ in 2024.

Where is the headquarters of FRESENIUS MEDICAL CARE FRANCE ?

The headquarters of FRESENIUS MEDICAL CARE FRANCE is located in FRESNES (94260), in the department Val-de-Marne.

Where to find the tax return of FRESENIUS MEDICAL CARE FRANCE ?

The tax return of FRESENIUS MEDICAL CARE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does FRESENIUS MEDICAL CARE FRANCE operate?

FRESENIUS MEDICAL CARE FRANCE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.